Peptide record

TPDB10892

Antibacterial Anticancer Antidiabetic Antifungal Hemolysis Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10892
Antibacterial Anticancer Antidiabetic Antifungal Hemolysis Toxicity
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia SATPdb dbACP AFP-GFuse Antifungipept CAFPdb dbAMP APD_complete APD_hemolytic Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 27-aa standard-residue multi-activity (Antibacterial, Anticancer, Antidiabetic, and other sources) peptide sequence curated from AntiBP3, Peptipedia, SATPdb, and other sources, with an available 3D structural model.
Sequence
GIFPIFAKLLGKVIKVASSLISKGRTE
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C135H230N34O34
NDCQHMWY
IK
2873.52
10.98
5
1
13
+4
0.07
0.648
130.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
4
Residue Composition
number
2
A
1
R
0
N
0
D
0
C
1
E
0
Q
3
G
0
H
4
I
3
L
4
K
0
M
2
F
1
P
3
S
1
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 2 R: 1 N: 0 D: 0 C: 0 E: 1 Q: 0 G: 3 H: 0 I: 4 L: 3 K: 4 M: 0 F: 2 P: 1 S: 3 T: 1 W: 0 Y: 0 V: 2
Chemical Descriptors
27 reviewed residue count
C135H230N34O34 sequence-only estimate (linear, free termini)
2873.52 sequence-only estimate (linear, free termini)
10.98 sequence-only estimate (linear, free termini)
+4 sequence-only estimate (linear, free termini)
0.07 sequence-only estimate (linear, free termini)
0.648 sequence-only estimate (linear, free termini)
Evidence Records 14 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5-10 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Active against S. aureus (MIC 5-10 uM), S. epidermidis (MIC 2.5-10 uM), E. faecalis (MIC 20 um), A. baumannii (10-20 uM), S. mal
Evidence 2 Activity

Activity

MIC
Antibacterial
2.5-10 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP

Other

Active against S. aureus (MIC 5-10 uM), S. epidermidis (MIC 2.5-10 uM), E. faecalis (MIC 20 um), A. baumannii (10-20 uM), S. maltophilia (10-40 uM), E. coli (80
Evidence 3 Activity

Activity

MIC
Antibacterial
20 um

Target

Enterococcus faecalis

Source & Reference

dbAMP

Other

Active against S. aureus (MIC 5-10 uM), S. epidermidis (MIC 2.5-10 uM), E. faecalis (MIC 20 um), A. baumannii (10-20 uM), S. maltophilia (10-40 uM), E. coli (80 uM), P. aeruginosa (80 u
Evidence 4 Activity

Activity

MIC
Antibacterial
80 µM

Target

Candida albicans

Source & Reference

dbAMP

Other

mannii (10-20 uM), S. maltophilia (10-40 uM), E. coli (80 uM), P. aeruginosa (80 uM), and C. albicans (MIC 80 uM). Toxic effects on cancer and normal cells: The peptide is also active against select canc
Evidence 5 Activity

Activity

MIC
Antifungal
5-10 µM

Target

Staphylococcus aureus

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Active against S. aureus (MIC 5-10 uM), S. epidermidis (MIC 2.5-10 uM), E. faecalis (MIC 20 um), A. baumannii (10-20 uM), S. mal
Evidence 6 Activity

Activity

MIC
Antifungal
2.5-10 µM

Target

Staphylococcus epidermidis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against S. aureus (MIC 5-10 uM), S. epidermidis (MIC 2.5-10 uM), E. faecalis (MIC 20 um), A. baumannii (10-20 uM), S. maltophilia (10-40 uM), E. coli (80
Evidence 7 Activity

Activity

MIC
Antifungal
20 um

Target

Enterococcus faecalis

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Active against S. aureus (MIC 5-10 uM), S. epidermidis (MIC 2.5-10 uM), E. faecalis (MIC 20 um), A. baumannii (10-20 uM), S. maltophilia (10-40 uM), E. coli (80 uM), P. aeruginosa (80 u
Evidence 8 Activity

Activity

MIC
Antifungal
80 µM

Target

Candida albicans

Source & Reference

dbAMP CAFPdb Antifungipept

Other

mannii (10-20 uM), S. maltophilia (10-40 uM), E. coli (80 uM), P. aeruginosa (80 uM), and C. albicans (MIC 80 uM). Toxic effects on cancer and normal cells: The peptide is also active against select canc
Evidence 9 Activity

Activity

LC50
Hemolysis
6.2
Human erythrocytes: LC50=6.2±1.0 µM

Target

Human erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Regul Pept. 2014 Nov 194-195:69-76.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 10 Activity

Activity

50% Cell death
Toxicity
68±2 µM
Cytotoxic
50% Cell death | 68±2 | µM | target cell: Human umbilical vein endothelial cells HUVEC

Target

Human umbilical vein endothelial cells HUVEC

Source & Reference

NA
DBAASP
Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa. | Regul Pept | 2014
Evidence 11 Activity

Activity

50% Hemolysis
Toxicity
6.2±1.0 µM
Hemolytic Cytotoxic
50% Hemolysis | 6.2±1.0 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Anti-cancer, immunoregulatory, and antimicrobial activities of the frog skin host-defense peptides pseudhymenochirin-1Pb and pseudhymenochirin-2Pa. | Regul Pept | 2014
Evidence 12 Activity

Activity

50% Hemolysis
Toxicity
7±2 µM
Hemolytic Cytotoxic
50% Hemolysis | 7±2 | µM | target cell: Mouse erythrocytes

Target

Mouse erythrocytes

Source & Reference

NA
DBAASP
Conformational Analysis of the Host-Defense Peptides Pseudhymenochirin-1Pb and -2Pa and Design of Analogues with Insulin-Releasing Activities and Reduced Toxicities. | J Nat Prod | 2015
Evidence 13 Activity

Activity

LC50
Toxicity
6.2
Hemolytic Cytotoxic
Hemolytic_activity: Human erythrocytes: LC50=6.2±1.0 µM | Cytotoxicity: HUVEC: LC50=68±2 µM

Target

erythrocytes

Source & Reference

NA
DRAMP
Regul Pept. 2014 Nov 194-195:69-76.
Evidence 14 Hemolysis

Activity

6.2
LC50
Human erythrocytes: LC50=6.2±1.0 µM
Hemolysis

Target

Human erythrocytes

Source & Reference

APD_complete APD_hemolytic PD_Hemolysis
Regul Pept. 2014 Nov 194-195:69-76.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.